SCHEMBL554289

SCHEMBL554289

CCOC(=O)C(C)=CC(=O)O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 2/20 0.48
GLO1 Q04760 1/20 0.48
HCAR2 Q8TDS4 1/20 0.45
ALDH1A1 P00352 6/20 0.44
LMNA P02545 2/20 0.44
HSD17B10 Q99714 1/20 0.44
CYP2C19 P33261 2/20 0.43
KDM4E B2RXH2 1/20 0.43
CYP1A2 P05177 1/20 0.43
CYP2D6 P10635 2/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
EGLN1 Q9GZT9 1/20 0.41
MAPT P10636 2/20 0.39
TRPA1 O75762 1/20 0.39
S1PR4 O95977 1/20 0.38
S1PR1 P21453 1/20 0.38
MAPK1 P28482 1/20 0.38
TSHR P16473 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL598483 1.00 NPSR1 (0.48) NPSR1GLO1HCAR2ALDH1A1LMNA
SCHEMBL7772643 1.00 NPSR1 (0.48) NPSR1GLO1HCAR2ALDH1A1LMNA
SCHEMBL2117165 0.85 ALDH1A1 (0.46) NPSR1GLO1HCAR2ALDH1A1LMNA
SCHEMBL243193 0.85 ALDH1A1 (0.46) NPSR1GLO1HCAR2ALDH1A1LMNA
SCHEMBL7037637 0.84 NPSR1 (0.50) NPSR1GLO1HCAR2ALDH1A1LMNA
SCHEMBL2547694 0.84 NPSR1 (0.50) NPSR1GLO1HCAR2ALDH1A1LMNA
SCHEMBL5052677 0.83 HCAR2 (0.48) NPSR1HCAR2ALDH1A1LMNACYP2C19
SCHEMBL7771261 0.83 HCAR2 (0.48) NPSR1HCAR2ALDH1A1LMNACYP2C19
SCHEMBL7770947 0.83 HCAR2 (0.48) NPSR1HCAR2ALDH1A1LMNACYP2C19
SCHEMBL5612231 0.82 NPSR1 (0.65) NPSR1GLO1HCAR2ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 428 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116143998-A Bio-based hydroxyl-terminated hyperbranched polyester, preparation method thereof and application thereof as plasticizer 上海交通大学 2023-05-23 CN claimed
US-20220105064-A1 CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER BIOGEN SWISS MFG GMBH (CH) 2022-04-07 US claimed
US-11229619-B2 Controlled release pharmaceutical compositions comprising a fumaric acid ester BIOGEN SWISS MANUFACTURING GMBH (CH) 2022-01-25 US claimed
US-20190201368-A1 CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER BIOGEN SWISS MANUFACTURING GMBH (CH) 2019-07-04 US claimed
US-20190117613-A1 CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER BIOGEN SWISS MANUFACTURING GMBH (CH) 2019-04-25 US claimed
CN-106770800-B The rapid detection method of 58 kinds of sensitization aromatic in a kind of articles for children 中国检验检疫科学研究院 2019-04-16 CN claimed
CN-109044985-A Pharmaceutical preparation comprising one of corrosion skeleton or a variety of fumarates 前进制药知识产权有限公司 2018-12-21 CN claimed
US-20180325855-A1 CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER FWP IP APS (DK) 2018-11-15 US claimed
US-20180263947-A1 CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER BIOGEN SWISS MANUFACTURING GMBH (CH) 2018-09-20 US claimed
US-20180221284-A1 PHARMACEUTICAL FORMULATION COMPRISING ONE OR MORE FUMARIC ACID ESTERS IN AN EROSION MATRIX BIOGEN SWISS MANUFACTURING GMBH (CH) 2018-08-09 US claimed
EP-2379062-A1 PHARMACEUTICAL COMPOSITION COMPRISING ONE OR MORE FUMARIC ACID ESTERS Forward Pharma A/S (DK) 2011-10-26 EP claimed
WO-2010079221-A1 PHARMACEUTICAL COMPOSITION COMPRISING ONE OR MORE FUMARIC ACID ESTERS FORWARD PHARMA A/S (DK) 2010-07-15 WO claimed
US-20090304790-A1 CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER ADITECH PHARMA AB (SE) 2009-12-10 US claimed
EP-2076554-A2 FLUORINATED SURFACTANTS AND METHOD OF MAKING THE SAME 3M Innovative Properties Company (US) 2009-07-08 EP claimed
US-20080299196-A1 Controlled Release Pharmaceutical Compositions Comprising a Fumaric Acid Ester ADITECH PHARMA AB (SE) 2008-12-04 US claimed
EP-1951206-A1 CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER Aditech Pharma AB (SE) 2008-08-06 EP claimed
WO-2008045999-A2 FLUORINATED SURFACTANTS AND METHOD OF MAKING THE SAME 3M INNOVATIVE PROPERTIES COMPANY (US) 2008-04-17 WO claimed
EP-1799196-A2 CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER Aditech Pharma AB (SE) 2007-06-27 EP claimed
WO-2007042034-A1 CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER ADITECH PHARMA AB (SE) 2007-04-19 WO claimed
WO-2006037342-A2 CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER ADITECH PHARMA AB (SE) 2006-04-13 WO claimed